ADIM
RNR icon

Alpha DNA Investment Management’s RenaissanceRe RNR Stock Holding History

Alpha DNA Investment Management’s Portfolio RNR Stock Details RNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23
Closed -$3K – 534
2021
Q1 		$3K Buy
23
+7
+44% +$1.13K ﹤0.01% 509
2020
Q4 		$2K Buy
+16
New +$2.72K ﹤0.01% 481

Other funds holding RNR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alpha DNA Investment Management's RNR Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of RenaissanceRe (RNR) in Q2 2021, closing a stake of 23 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in RNR in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 355 funds tracked by Wall St. Rank hold RNR as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining RenaissanceRe position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 23 RenaissanceRe shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in RenaissanceRe in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's RenaissanceRe position peaked at $3K in Q1 2021.
  • 355 funds tracked by Wall St. Rank held RenaissanceRe as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.